Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Elevated Lymphocytes Predict Survival Outcomes in Early Breast Cancer
1
Mins
July 2024
Synergistic Immune-Mediated Anti-tumour Effect of Dostarlimab and Radiotherapy in the Management of MSI-H/dMMR Endometrial Cancer: A Case Report.
Read more
3
Mins
12th July 2017
Updated St. Gallen International Breast Cancer Guidelines Reinforce Important Role of Genomic Testing in Treatment of Early Breast Cancer
Geneva, Switzerland, 12 July, 2017 – Genomic Health today announced that the 15th St. Gallen International Breast Cancer Conference Expert Panel endorsed…
4
Mins
11th July 2017
Agendia’s MammaPrint® Recommended by ASCO Breast Cancer Guideline in Focused Update Based on Landmark MINDACT Trial Data
ASCO recommends MammaPrint® for clinical high risk, hormone receptor-positive, HER2-negative breast cancer, to inform decisions on withholding chemotherapy
2
Mins
13th June 2017
PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers
PharmaMar announces encouraging results in clinical trials of Lurbinectedin in endometrial and breast cancers. Find out more
3
Mins
6th June 2017
Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting
Oxford, UK and Conshohocken, US, 5 June, 2017 – Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer…
3
Mins
5th June 2017
F-Star Expands Its Relationship with Merck Through a New Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology
Cambridge, UK, June 04, 2017 – F-star, a biopharmaceutical company developing novel bispecific antibodies, announces today a new partnership with Merck…
5
Mins
5th June 2017
Darzalex®▼ (daratumumab) Combination Therapy Improved Clinical Outcomes Regardless of Cytogenetic Risk for Previously-Treated Patients with Multiple Myeloma
Beerse, Belgium, June 4, 2017 – Janssen-Cilag International NV (“Janssen”) today announced new data from updated analyses of the pivotal Phase 3 CASTOR…
2
Mins
24th May 2017
Immunoscore®, Immunosign® and Halioseek™ at ASCO 2017
Marseille, France, May 23, 2017 – HalioDx SAS, an immuno-oncology diagnostic company, announced its participation at the 2017 American Society of…
3
Mins
16th May 2017
Philips Showcases New Integrated Image-Guided Therapy Solutions at 2017 EuroPCR to Transform Cardiac Care and Help Improve Patient Care
Amsterdam, May 16, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA) will showcase its market-leading image guided therapy solutions at EuroPCR 2017…
Loading posts...
« Previous
1
…
17
18
19
20
21
…
32
Next »